Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Specialty Generics Market Report 2017 - Rise in Demand for Low-Cost Generic Specialty Drugs - Research and Markets

Research and Markets
Posted on: 03 Nov 17

The "Specialty Generics Market Analysis By Type, By End-use, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global specialty generics market is expected to reach USD 174.9 billion by 2025, according to a new report.

Rise in demand for low-cost generic specialty drugs is a major factor estimated to accelerate the market growth during the forecast period. Introduction of cost-effective drugs for the treatment of multiple sclerosis, cancer, and other infectious diseases is expected to showcase huge opportunities for the specialty generic drug manufacturers. According to U.S. FDA, generic drugs cost 80% to 85% lower as compared to branded drugs. One of the factors contributing to their affordable price is that they do not need to repeat expensive clinical trials, advertising, and promotional activities. Thus, low cost of generic specialty drugs is expected to accelerate the demand for these medicines.

Rise in number of off-patent specialty drugs is another major factor expected to support growth of the specialty generic drugs market. For instance, the patent for Gilenya, a blockbuster drug by Novartis, will expire in 2019. This drug led to USD 3.1 billion in sales in 2016 for Novartis, with 14% sales growth. In April 2017, Novartis failed to acquire patent extension for Gilenya till 2026 in the U.S. Federal Circuit. Such early patent expirations are expected to boost the entry of new generics.

Companies Mentioned

  • Teva Pharmaceuticals USA, Inc.
  • Mylan N.V.
  • Sandoz International GmbH
  • Akorn, Inc.
  • Mallinckrodt
  • Valeant Pharmaceuticals International, Inc.
  • Pfizer Inc.
  • Endo Pharmaceuticals Inc.
  • Apotex Corp.
  • Sun Pharmaceutical Industries Ltd.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Specialty Generics Market Variables, Trends & Scope

Chapter 4 Specialty Generics Market: Type Estimates & Trend Analysis

Chapter 5 Specialty Generics Market: Application Estimates & Trend Analysis

Chapter 6 Specialty Generics Market: End-use Estimates & Trend Analysis

Chapter 7 Specialty Generics Market: Regional Estimates & Trend Analysis, by Type, Application, End-use

Chapter 8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/ns7x7v/specialty

View source version on businesswire.com: http://www.businesswire.com/news/home/20171103005303/en/

Business Wire
www.businesswire.com

Last updated on: 03/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.